VRS
MACK

Virginia Retirement Systems’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Virginia Retirement Systems’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,860
Closed -$198K – 1050
2014
Q3 		$198K Sell
2,860
-635
-18% -$33.9K ﹤0.01% 926
2014
Q2 		$200K Buy
+3,495
New +$177K ﹤0.01% 924

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Virginia Retirement Systems's MACK Position: Q4 2014 in Review

Virginia Retirement Systems sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2014, closing a stake of 2,860 shares — an estimated $198K sold.

Virginia Retirement Systems first reported a position in MACK in Q2 2014 and held it in 2 quarters. The position peaked at $200K in Q2 2014. 143 funds tracked by Wall St. Rank hold MACK as of Q4 2014.

  • Virginia Retirement Systems reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Virginia Retirement Systems sold 2,860 Merrimack Pharmaceuticals, Inc. shares in Q4 2014, an estimated $198K.
  • Virginia Retirement Systems first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Virginia Retirement Systems's Merrimack Pharmaceuticals, Inc. position peaked at $200K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2014.

Based on Virginia Retirement Systems's 13F filing for Q4 2014, filed 28 Jan 2015.